Literature DB >> 21510917

Relationship between membrane permeability and specificity of human secretory phospholipase A(2) isoforms during cell death.

Jennifer Nelson1, Elizabeth Gibbons, Katalyn R Pickett, Michael Streeter, Ashley O Warcup, Celestine H-Y Yeung, Allan M Judd, John D Bell.   

Abstract

During apoptosis, a number of physical changes occur in the cell membrane including a gradual increase in permeability to vital stains such as propidium iodide. This study explored the possibility that one consequence of membrane changes concurrent with early modest permeability is vulnerability to degradation by secretory phospholipase A(2). The activity of this hydrolytic enzyme toward mammalian cells depends on the health of the cell; healthy cells are resistant, but they become susceptible early during programmed death. Populations of S49 lymphoma cells during programmed death were classified by flow cytometry based on permeability to propidium iodide and susceptibility to secretory phospholipase A(2). The apoptotic inducers thapsigargin and dexamethasone caused modest permeability to propidium iodide and increased staining by merocyanine 540, a dye sensitive to membrane perturbations. Various secretory phospholipase A(2) isozymes (human groups IIa, V, X, and snake venom) preferentially hydrolyzed the membranes of cells that displayed enhanced permeability. In contrast, cells exposed briefly to a calcium ionophore showed the increase in cell staining intensity by merocyanine 540 without accompanying uptake of propidium iodide. Under that condition, only the snake venom and human group X enzymes hydrolyzed cells that were dying. These results suggested that cells showing modest permeability to propidium iodide during the early phase of apoptosis are substrates for secretory phospholipase A(2) and that specificity among isoforms of the enzyme depends on the degree to which the membrane has been perturbed during the death process. This susceptibility to hydrolysis may be important as part of the signal to attract macrophages toward apoptotic cells.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21510917      PMCID: PMC3102113          DOI: 10.1016/j.bbamem.2011.04.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  70 in total

1.  The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall.

Authors:  Stephen A Beers; Andrew G Buckland; Rao S Koduri; Wonhwa Cho; Michael H Gelb; David C Wilton
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

2.  Molecular suicide notes: last call from apoptosing cells.

Authors:  Christoph Peter; Sebastian Wesselborg; Kirsten Lauber
Journal:  J Mol Cell Biol       Date:  2009-12-11       Impact factor: 6.216

3.  The relationship between cell membrane damage and lipid peroxidation under the condition of hypoxia-reoxygenation: analysis of the mechanism using antioxidants and electron transport inhibitors.

Authors:  Daisuke Yajima; Hisako Motani; Mutsumi Hayakawa; Yayoi Sato; Kaoru Sato; Hirotaro Iwase
Journal:  Cell Biochem Funct       Date:  2009-08       Impact factor: 3.685

4.  Relationship between erythrocyte membrane phase properties and susceptibility to secretory phospholipase A2.

Authors:  Katrina B Best; Allison J Ohran; Andrea C Hawes; Theodore L Hazlett; Enrico Gratton; Allan M Judd; John D Bell
Journal:  Biochemistry       Date:  2002-11-26       Impact factor: 3.162

5.  Susceptibility of S49 lymphoma cell membranes to hydrolysis by secretory phospholipase A(2) during early phase of apoptosis.

Authors:  K H Nielson; C A Olsen; D V Allred; K L O'Neill; G F Burton; J D Bell
Journal:  Biochim Biophys Acta       Date:  2000-04-12

6.  Crystal structure of human group X secreted phospholipase A2. Electrostatically neutral interfacial surface targets zwitterionic membranes.

Authors:  Ying H Pan; Bao-Zhu Yu; Alan G Singer; Farideh Ghomashchi; Gerard Lambeau; Michael H Gelb; Mahendra K Jain; Brian J Bahnson
Journal:  J Biol Chem       Date:  2002-05-25       Impact factor: 5.157

7.  On the binding preference of human groups IIA and X phospholipases A2 for membranes with anionic phospholipids.

Authors:  Sofiane Bezzine; James G Bollinger; Alan G Singer; Sarah L Veatch; Sarah L Keller; Michael H Gelb
Journal:  J Biol Chem       Date:  2002-09-19       Impact factor: 5.157

8.  Opposite effects of native and oxidized lipoproteins on the activity of secretory phospholipase A(2) group IIA.

Authors:  Aleksandra A Korotaeva; Elena V Samoilova; Aleksandra A Pirkova; Vera A Ameliushkina; Nina V Prokazova; Vsevolod A Tkachuk; Eugeny I Chazov
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-07-30       Impact factor: 3.072

Review 9.  Catalytic and non-catalytic functions of human IIA phospholipase A2.

Authors:  Charles N Birts; C Howard Barton; David C Wilton
Journal:  Trends Biochem Sci       Date:  2009-10-08       Impact factor: 13.807

10.  Oxidized phosphatidylcholine stimulates activity of secretory phospholipase A2 group IIA and abolishes sphingomyelin-induced inhibition of the enzyme.

Authors:  Aleksandra A Korotaeva; Elena V Samoilova; Galina F Piksina; Nina V Prokazova
Journal:  Prostaglandins Other Lipid Mediat       Date:  2010-01-04       Impact factor: 3.072

View more
  12 in total

1.  Investigation into the role of phosphatidylserine in modifying the susceptibility of human lymphocytes to secretory phospholipase A(2) using cells deficient in the expression of scramblase.

Authors:  Jennifer Nelson; Lyndee L Francom; Lynn Anderson; Kelly Damm; Ryan Baker; Joseph Chen; Sarah Franklin; Amy Hamaker; Izadora Izidoro; Eric Moss; Mikayla Orton; Evan Stevens; Celestine Yeung; Allan M Judd; John D Bell
Journal:  Biochim Biophys Acta       Date:  2012-01-13

Review 2.  Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease.

Authors:  Nhat D Quach; Robert D Arnold; Brian S Cummings
Journal:  Biochem Pharmacol       Date:  2014-06-04       Impact factor: 5.858

3.  Molecular details of membrane fluidity changes during apoptosis and relationship to phospholipase A(2) activity.

Authors:  Elizabeth Gibbons; Katalyn R Pickett; Michael C Streeter; Ashley O Warcup; Jennifer Nelson; Allan M Judd; John D Bell
Journal:  Biochim Biophys Acta       Date:  2012-09-04

4.  TRPV4 Protects the Lung from Bacterial Pneumonia via MAPK Molecular Pathway Switching.

Authors:  Rachel G Scheraga; Susamma Abraham; Lisa M Grove; Brian D Southern; James F Crish; Apostolos Perelas; Christine McDonald; Kewal Asosingh; Jeffrey D Hasday; Mitchell A Olman
Journal:  J Immunol       Date:  2020-01-22       Impact factor: 5.422

5.  Global changes in gene expression by the opportunistic pathogen Burkholderia cenocepacia in response to internalization by murine macrophages.

Authors:  Jennifer S Tolman; Miguel A Valvano
Journal:  BMC Genomics       Date:  2012-02-09       Impact factor: 3.969

6.  Group X secreted phospholipase A(2) induces lipid droplet formation and prolongs breast cancer cell survival.

Authors:  Anja Pucer; Vesna Brglez; Christine Payré; Jože Pungerčar; Gérard Lambeau; Toni Petan
Journal:  Mol Cancer       Date:  2013-09-27       Impact factor: 27.401

7.  Synergistic effects of secretory phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus with cancer chemotherapeutic agents.

Authors:  Jennifer Nelson; Kristen Barlow; D Olin Beck; Amanda Berbert; Nathan Eshenroder; Lyndee Francom; Mark Pruitt; Kina Thompson; Kyle Thompson; Brian Thurber; Celestine H-Y Yeung; Allan M Judd; John D Bell
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

8.  Inclusion Complex of Zerumbone with Hydroxypropyl- β -Cyclodextrin Induces Apoptosis in Liver Hepatocellular HepG2 Cells via Caspase 8/BID Cleavage Switch and Modulating Bcl2/Bax Ratio.

Authors:  Nabilah Muhammad Nadzri; Ahmad Bustamam Abdul; Mohd Aspollah Sukari; Siddig Ibrahim Abdelwahab; Eltayeb E M Eid; Syam Mohan; Behnam Kamalidehghan; Theebaa Anasamy; Kuan Beng Ng; Suvitha Syam; Ismail Adam Arbab; Heshu Sulaiman Rahman; Hapipah Mohd Ali
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-08       Impact factor: 2.629

9.  Lactadherin inhibits secretory phospholipase A2 activity on pre-apoptotic leukemia cells.

Authors:  Steffen Nyegaard; Valerie A Novakovic; Jan T Rasmussen; Gary E Gilbert
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

10.  Loss of membrane integrity drives myofiber death in lipin1-deficient skeletal muscle.

Authors:  Sandhya Ramani Sattiraju; Abdulrahman Jama; Abdullah A Alshudukhi; Nicholas Edward Townsend; Daniel Reynold Miranda; Rebecca R Reese; Andrew A Voss; Hongmei Ren
Journal:  Physiol Rep       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.